A 101 in Biotech Financial Risk Management

Time: 2:05 pm
day: PRE-CONFERENCE WORKSHOP DAY

Details:

• How to demonstrate value proposition and attract investment as a biotech with a novel vector platform
• ‘Build vs Buy’: weighing up whether to develop or license functionalities
• Identifying healthy business development opportunities
• Diversifying risk across a portfolio

Speakers:

Alex Goraltchouk Alex is an Operations, Engineering, and R&D executive having held roles of increasing responsibility at companies ranging from start-up to Fortune 500 including Allergan, Biogen, Read more

Caroline Xu

Don Haut Don is a life sciences senior executive and deal-maker with over 20 years of experience. He has executed transactions worth a total of more than $8.5 billion, Read more